SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech informs about closure of trading window

31 Dec 2024 Evaluate

Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company's Code of Conduct for Prevention of Insider Trading and BSE circular no. LIST/COMP/01/2019-20 dated April 2, 2019 regarding intimation for closure of Trading Window, Fermenta Biotech has informed that the ‘Trading Window’ i.e. period for trading in Company’s securities, will be closed with effect from January 01, 2025 till 48 hours after the declaration of financial results for the quarter and nine months ended December 31, 2024, as may be approved at the concerned Board Meeting. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company’s equity shares, either in their own name or in the name of their immediate relatives. The intimation regarding the Board Meeting date will be announced in due course. Terms not defined in this notice shall have the same meaning as defined in the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders. 

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

301.30 2.70 (0.90%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×